CXCR4 as a predictive marker for locally advanced breast cancer post-neoadjuvant therapy

Journal of Surgical Research

Volumn 166, Issue 1, 2011, Pages 14-18

  Hiller, David J ^a   Li, Benjamin D L ^a   Chu, Quyen D ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

chemokine receptor CXCR4; locally advanced breast cancer; predictive marker

Indexed keywords

CAPECITABINE; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TUMOR MARKER; ZOLEDRONIC ACID;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LOG RANK TEST; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG MONITORING; FEMALE; HELA CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY, RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951675671     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.04.045     Document Type: Article

References (19)

1. F.L. Greene, D.L. Page, and I.D. Fleming AJCC cancer staging manual 6th edition 2002 Spring-Verlag New York
2. B. Fisher, J. Bryant, and N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672
3. S. Moulder, and G.N. Hortobagyi Advances in treatment of breast cancer Clinical Pharm Therapeut 83 2003 26
4. R.W. Carlson, and A.M. Favret Multidisciplinary management of locally advanced breast cancer Breast J 5 1999 303
5. S.M. Scholl, J.Y. Pierga, and B. Asselain Breast tumor response to primary chemotherapy predicts local and distant control as well as survival Eur J Cancer 31 1995 1969
6. J.C. Chang, E.C. Wooten, and A. Tsimelzon Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer Lancet 326 2003 362
7. N. Holm, K. Byrnes, and L. Johnson A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer Ann Surg Oncol 15 2008 3207
8. D.R. McClusky, Q. Chu, and H. Yu A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer Ann Surg 242 2005 584
9. D. Hiller, Q. Chu, and C. Meschonat Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer J Surg Res 156 2009 265
10. A. Muller, B. Homey, and H. Soto Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50
11. N. Holm, F. Abreo, and L. Johnson Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer Breast Cancer Res Treat 113 2009 293
12. Q. Chu, L. Panu, and T. Holm High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome J Surg Res 159 2009 689
13. W.G. Cance, L.A. Carey, and B.F. Calvo Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: Effective clinical downstaging allows breast preservation and predicts outstanding local control and survival Ann Surg 97 2002 1137
14. G.N. Hortobagyi, F.C. Ames, and A.U. Buzdar Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy Cancer 62 1988 2507
15. S. Singletary, M. McNeese, and G. Hortobagyi Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma Cancer 69 1992 2849
16. M. Alassas, Q. Chu, and G. Burton Neoadjuvant chemotherapy in stage III breast cancer Am Surgeon 71 2005 487
17. M. Smith, K. Luker, and J. Garbow CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 2004 8604
18. N. Holm, K. Byrnes, and B. Li Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence J Surg Res 141 2007 91
19. Y. Li, and Y. Pan Up-regulation of CXCR4 is essential for HER2-mediated tumor metastasis Cancer Cell 6 2004 459